🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II clinical trial to assess the efficacy of donor regulatory enriched...
Status
Unknown
Location
José Antonio Pérez Simón
Start Date
2022-03-24
Trial ID
NCT05095649
Treatments Being Tested
This is a INTERVENTIONAL TRANSPLANTATION STUDY WITHOUT DRUGS. The INTERVEN...
Status
Completed
Location
University Hospital St. Orsola-Malpighi Polyclinic
Start Date
2016-08-03
Trial ID
NCT02749084
Treatments Being Tested
A Phase I Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic ...
Status
Completed
Location
Hospital Universitario Virgen del Rocío
Start Date
2018-09-25
Trial ID
NCT03683498
Treatments Being Tested
Two key methods of GVHD prevention in allogeneic HSCT have a number of limi...
Status
Recruiting
Location
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198
Start Date
2025-09-03
Trial ID
NCT07366801
Treatments Being Tested
This research study is a Phase I clinical trial, which tests the safety of ...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Start Date
2013-11
Trial ID
NCT01937468
Treatments Being Tested
Open single armed study to investigate safety and feasibility of administra...
Status
Unknown
Location
Karolinska University Hospital
Start Date
2018-08-20
Trial ID
NCT04820270
Treatments Being Tested
This research study is evaluating the safety and efficacy of the IS-free Tr...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2021-01-12
Trial ID
NCT04678401
This phase I trial tests the side effects and best dose of total marrow lym...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-05-24
Trial ID
NCT06195891
Treatments Being Tested
Reduced intensity conditioning (RIC) has emerged and been increasingly adop...
Status
Active Not Recruiting
Location
Stanford University
Start Date
2021-09-07
Trial ID
NCT05088356
Patients with hematologic malignancies will receive myeloablative chemother...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2009-06
Trial ID
NCT01050764